Send feedback

CSF2RA p.Arg227=

c.681T>C · rs186487689 · VCV751935

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 4 submitters
gnomAD v4.1
Rare
ultra-rare (popmax 0.034%, sas)
Conditions
1
surfactant metabolism dysfunction, pulmonary, 4

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -3.2GERP -5.7
Overall
CADD2.434PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.034% South Asian · 31/91,058 alleles
Filtering AF 0.0246% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0214%
Overall 0.00973% 157/1,613,792 alleles · ultra-rare
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.25% 400
South Asiangrpmax 0.034% 2,937
Remaining individualsnot grpmax-eligible 0.0256% 3,905
Middle Eastern 0.0166% 6,010
Admixed American 0.0133% 7,499
European (non-Finnish) 0.0022% 45,378
African / African-American 0.00133% 75,004

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
CSF2RA
Protein
p.Arg227=
Coding
c.681T>C
MANE Select
NM_172245
dbSNP
rs186487689
Type
single nucleotide variant
Location
chrX:1294362 (GRCh38)
Structure
AlphaFold pLDDT 82.15 · 2 PDB
Residue 227
a β-strand; the fibronectin type-iii domain
Full CSF2RA gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

surfactant metabolism dysfunction, pulmonary, 4 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Hereditary pulmonary alveolar proteinosis (Orphanet):

Inheritance
Autosomal recessive
Onset
Adolescent, Adult, Childhood, Elderly, Infancy
Prevalence
<1 / 1 000 000 (Worldwide)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/csf2ra-p-arg227 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown